Inogen IncINGN
What Inogen Inc does.
Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox ® product for airway clearance treatment. In addition, we have started distributing the Inogen Voxi ® 5 stationary oxygen concentrator as well as the Aurora ® continuous positive airway pressure, or CPAP, masks in the United States. Our proprietary Inogen One ® and Inogen Rove ® POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. While often used together with stationary oxygen concentrators and oxygen compressed gas tanks, our POCs are designed to reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen, thereby improving patient quality of life and fostering mobility. Our Simeox product is a technology-enabled mucus management device predominantly aimed at serving patients requiring airway clearance, such as those with bronchiectasis – a condition characterized by damaged and widened bronchi that can occur in patients with cystic fibrosis, chronic obstructive pulmonary disease, or COPD, or other chronic respiratory diseases. The Voxi 5 stationary oxygen concentrator is used to provide continuous, long-term oxygen therapy to patients who need supplemental oxygen at home or in clinical settings. The Aurora CPAP masks are used to deliver CPAP therapy through a separate device primarily for treating obstructive sleep apnea, or OSA.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $308.5M | $358.0M | $377.2M | $315.7M | $335.7M | $348.7M |
| Net income | -$5.8M | -$6.3M | -$83.8M | -$102.4M | -$35.9M | -$22.7M |
| Free cash flow | $32.6M | $18.2M | -$40.9M | -$8.5M | $2.6M | -$13.7M |
More on INGN.
- Inogen Inc summary
- Inogen Inc financial statements
- Inogen Inc key metrics
- Inogen Inc health scores and style box
- Inogen Inc earnings
- Inogen Inc dividends
- Inogen Inc valuation
- Inogen Inc ownership and insiders
- Inogen Inc peers
Figures from Inogen Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.